Dr. Reddy's Laboratories Limited
RDY
$12.11
-$0.11-0.90%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 370.66M | 489.39M | 650.25M | 681.74M | 666.99M |
| Total Depreciation and Amortization | 232.19M | 231.01M | 224.67M | 222.02M | 211.62M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 24.55M | 56.49M | 60.44M | 10.53M | 32.17M |
| Change in Net Operating Assets | -170.96M | -139.69M | -209.47M | -232.47M | -296.12M |
| Cash from Operations | 456.44M | 637.20M | 725.90M | 681.82M | 614.66M |
| Capital Expenditure | -219.33M | -263.24M | -303.78M | -313.71M | -343.85M |
| Sale of Property, Plant, and Equipment | 6.80M | 3.41M | 1.63M | 2.83M | 4.09M |
| Cash Acquisitions | -35.66M | -33.33M | -19.12M | -19.12M | -633.24M |
| Divestitures | 52.90K | -- | -- | -- | -- |
| Other Investing Activities | -216.16M | -436.00M | -281.50M | -221.85M | 302.79M |
| Cash from Investing | -464.29M | -729.16M | -602.77M | -551.85M | -670.22M |
| Total Debt Issued | 20.19B | 20.26B | 6.75B | -391.00M | 13.99B |
| Total Debt Repaid | -6.76B | -1.26B | -1.11B | -1.12B | -1.32B |
| Issuance of Common Stock | 449.00M | 397.00M | 329.00M | 324.00M | 370.00M |
| Repurchase of Common Stock | -- | -- | -1.39B | -1.39B | -1.39B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -76.27M | -76.27M | -76.27M | -76.27M | -79.53M |
| Other Financing Activities | -4.84B | -4.44B | -4.05B | -4.07B | 3.17B |
| Cash from Financing | 25.42M | 86.70M | -72.87M | -153.19M | 100.59M |
| Foreign Exchange rate Adjustments | 12.09M | 13.75M | 11.04M | 6.96M | 4.45M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 29.66M | 8.48M | 61.29M | -16.26M | 49.48M |